Newsfeeds - Spark Newswire

2 minute read

Adamis Pharmaceuticals Announces $3M Registered Direct Offering With A Single, Healthcare-Focused Institutional Investor

March 14, 8:33 AM

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including opioid overdose,

ADMP

4 minute read

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

March 3, 2:20 PM

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

ADMP

3 minute read

Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

March 1, 2:16 PM

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

ADMP

1 minute read

Adamis Pharmaceuticals Q3 EPS $(0.03), Inline, Sales $1.51M Beat $500.00K Estimate

By Benzinga Newsdesk

November 14, 5:24 PM

Adamis Pharmaceuticals (NASDAQ:ADMP) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.06) per share from the same period last year.

ADMP

17 minute read

Earnings

Earnings Scheduled For November 14, 2022

By Benzinga Insights

November 14, 6:06 AM

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC